{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,3,20]],"date-time":"2023-03-20T22:30:12Z","timestamp":1679351412769},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2010,3,23]],"date-time":"2010-03-23T00:00:00Z","timestamp":1269302400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathol. Oncol. Res."],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1007\/s12253-010-9255-9","type":"journal-article","created":{"date-parts":[[2010,3,22]],"date-time":"2010-03-22T07:39:00Z","timestamp":1269243540000},"page":"563-568","source":"Crossref","is-referenced-by-count":7,"title":["R72P Polymorphism of TP53 in Ulcerative Colitis Patients is Associated with the Incidence of Colectomy, Use of Steroids and the Presence of a Positive Family History"],"prefix":"10.1007","volume":"16","author":[{"given":"Fatih","family":"Eren","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"Akkiprik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00d6zlen","family":"Atu\u011f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00d6zg\u00fcr","family":"S\u00f6nmez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00fclg\u00fcn","family":"Tahan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filiz","family":"\u00d6zdemir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00fclya \u00d6ver","family":"Hamzao\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c7i\u011fdem Ataizi","family":"\u00c7elikel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ne\u015fe","family":"\u0130mery\u00fcz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erol","family":"Av\u015far","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ay\u015fe","family":"\u00d6zer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,3,23]]},"reference":[{"key":"9255_CR1","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/sj.onc.1201263","volume":"15","author":"D Sakamuro","year":"1997","unstructured":"Sakamuro D, Sabbatini P, White E et al (1997) The polyproline region of p53 is required to activate apoptosis but not growth arrest. Oncogene 15:887\u2013898","journal-title":"Oncogene"},{"key":"9255_CR2","doi-asserted-by":"crossref","first-page":"15335","DOI":"10.1073\/pnas.93.26.15335","volume":"93","author":"KK Walker","year":"1996","unstructured":"Walker KK, Levine AJ (1996) Identification of a novel p53 functional domain that is necessary for efficient growth suppression. Proc Natl Acad Sci U S A 93:15335\u201315340","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9255_CR3","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nrc2584","volume":"9","author":"C Whibley","year":"2009","unstructured":"Whibley C, Pharoah PD, Hollstein M (2009) p53 polymorphisms: cancer implications. Nat Rev Cancer 9:95\u2013107","journal-title":"Nat Rev Cancer"},{"key":"9255_CR4","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/75586","volume":"25","author":"MC Marin","year":"2000","unstructured":"Marin MC, Jost CA, Brooks LA et al (2000) A common polymorphism acts as an intragenic modifier of mutant p53 behaviour. Nat Genet 25:47\u201354","journal-title":"Nat Genet"},{"key":"9255_CR5","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1038\/sj.onc.1207305","volume":"23","author":"F Gemignani","year":"2004","unstructured":"Gemignani F, Moreno V, Landi S et al (2004) A TP53 polymorphism is associated with increased risk of colorectal cancer and with reduced levels of TP53 mRNA. Oncogene 23:1954\u20131956","journal-title":"Oncogene"},{"key":"9255_CR6","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/ng1093","volume":"33","author":"P Dumont","year":"2003","unstructured":"Dumont P, Leu JI, Della Pietra AC et al (2003) The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet 33:357\u2013365","journal-title":"Nat Genet"},{"key":"9255_CR7","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1038\/sj.onc.1207428","volume":"23","author":"A Sullivan","year":"2004","unstructured":"Sullivan A, Syed N, Gasco M et al (2004) Polymorphism in wild-type p53 modulates response to chemotherapy in vitro and in vivo. Oncogene 23:3328\u20133337","journal-title":"Oncogene"},{"key":"9255_CR8","doi-asserted-by":"crossref","first-page":"7328","DOI":"10.1158\/1078-0432.CCR-05-0507","volume":"11","author":"Y Xu","year":"2005","unstructured":"Xu Y, Yao L, Ouyang T et al (2005) p53 Codon 72 polymorphism predicts the pathologic response to neoadjuvant chemotherapy in patients with breast cancer. Clin Cancer Res 11:7328\u20137333","journal-title":"Clin Cancer Res"},{"key":"9255_CR9","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1093\/carcin\/bgi125","volume":"26","author":"HH Nelson","year":"2005","unstructured":"Nelson HH, Wilkojmen M, Marsit CJ et al (2005) TP53 mutation, allelism and survival in non-small cell lung cancer. Carcinogenesis 26:1770\u20131773","journal-title":"Carcinogenesis"},{"key":"9255_CR10","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1056\/NEJM199011013231802","volume":"323","author":"A Ekbom","year":"1990","unstructured":"Ekbom A, Helmick C, Zack M et al (1990) Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med 323:1228\u20131233","journal-title":"N Engl J Med"},{"key":"9255_CR11","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/0016-5085(92)91184-6","volume":"103","author":"GC Burmer","year":"1992","unstructured":"Burmer GC, Rabinovitch PS, Haggitt RC et al (1992) Neoplastic progression in ulcerative colitis: histology, DNA content, and loss of a p53 allele. Gastroenterology 103:1602\u20131610","journal-title":"Gastroenterology"},{"key":"9255_CR12","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0016-5085(94)90161-9","volume":"107","author":"TA Brentnall","year":"1994","unstructured":"Brentnall TA, Crispin DA, Rabinovitch PS et al (1994) Mutations in the p53 gene: an early marker of neoplastic progression in ulcerative colitis. Gastroenterology 107:369\u2013378","journal-title":"Gastroenterology"},{"key":"9255_CR13","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/0046-8177(94)90067-1","volume":"25","author":"N Harpaz","year":"1994","unstructured":"Harpaz N, Peck AL, Yin J et al (1994) p53 protein expression in ulcerative colitis-associated colorectal dysplasia and carcinoma. Hum Pathol 25:1069\u20131074","journal-title":"Hum Pathol"},{"key":"9255_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1097-0215(19980330)76:1<1::AID-IJC1>3.0.CO;2-4","volume":"76","author":"K Holzmann","year":"1998","unstructured":"Holzmann K, Klump B, Borchard F et al (1998) Comparative analysis of histology, DNA content, p53 and Ki-ras mutations in colectomy specimens with long-standing ulcerative colitis. Int J Cancer 76:1\u20136","journal-title":"Int J Cancer"},{"key":"9255_CR15","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1572-0241.1999.877_f.x","volume":"94","author":"BA Lashner","year":"1999","unstructured":"Lashner BA, Shapiro BD, Husain A et al (1999) Evaluation of the usefulness of testing for p53 mutations in colorectal cancer surveillance for ulcerative colitis. Am J Gastroenterol 94:456\u2013462","journal-title":"Am J Gastroenterol"},{"key":"9255_CR16","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3109\/00365528909091339","volume":"170","author":"JE Lennard-Jones","year":"1989","unstructured":"Lennard-Jones JE (1989) Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl 170:2\u20136","journal-title":"Scand J Gastroenterol Suppl"},{"key":"9255_CR17","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/j.1572-0241.2001.03671.x","volume":"96","author":"SB Hanauer","year":"2001","unstructured":"Hanauer SB, Sandborn W (2001) Management of Crohn\u2019s Disease in adults. Am J Gastroenterol 96:635\u2013643","journal-title":"Am J Gastroenterol"},{"key":"9255_CR18","first-page":"252","volume":"10","author":"R Soong","year":"1997","unstructured":"Soong R, Iacopetta BJ (1997) A rapid and nonisotopic method for the screening and sequencing of p53 gene mutations in formalin fixed, paraffin-embedded tumours. Med Pathol 10:252\u2013258","journal-title":"Med Pathol"},{"key":"9255_CR19","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.canlet.2005.04.014","volume":"229","author":"ZZ Zhu","year":"2005","unstructured":"Zhu ZZ, Cong WM, Liu SF et al (2005) A p53 polymorphism modifies the risk of hepatocellular carcinoma among non-carriers but not carriers of chronic hepatitis B virus infection. Cancer Lett 229:77\u201383","journal-title":"Cancer Lett"},{"key":"9255_CR20","first-page":"25","volume":"109","author":"N Sayhan","year":"2001","unstructured":"Sayhan N, Yazici H, Budak M et al (2001) P53 codon 72 genotypes in colon cancer. Association with human papillomavirus infection. Res Commun Mol Pathol Pharmacol 109:25\u201334","journal-title":"Res Commun Mol Pathol Pharmacol"},{"key":"9255_CR21","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/jjco\/hym034","volume":"37","author":"ZZ Zhu","year":"2007","unstructured":"Zhu ZZ, Wang AZ, Jia HR et al (2007) Association of the TP53 codon 72 polymorphism with colorectal cancer in a Chinese population. Jpn J Clin Oncol 37:385\u2013390","journal-title":"Jpn J Clin Oncol"},{"key":"9255_CR22","doi-asserted-by":"crossref","first-page":"114","DOI":"10.4149\/neo_2009_02_114","volume":"56","author":"Z Cao","year":"2009","unstructured":"Cao Z, Song JH, Park YK et al (2009) The p53 codon 72 polymorphism and susceptibility to colorectal cancer in Korean patients. Neoplasma 56:114\u2013118","journal-title":"Neoplasma"},{"key":"9255_CR23","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.3748\/wjg.v12.i9.1426","volume":"12","author":"LO P\u00e9rez","year":"2006","unstructured":"P\u00e9rez LO, Abba MC, Dulout FN et al (2006) Evaluation of p53 codon 72 polymorphism in adenocarcinomas of the colon and rectum in La Plata, Argentina. World J Gastroenterol 12:1426\u20131429","journal-title":"World J Gastroenterol"},{"key":"9255_CR24","first-page":"1039","volume":"28","author":"A Dakouras","year":"2008","unstructured":"Dakouras A, Nikiteas N, Papadakis E et al (2008) P53Arg72 homozygosity and its increased incidence in left-sided sporadic colorectal adenocarcinomas, in a Greek-Caucasian population. Anticancer Res 28:1039\u20131043","journal-title":"Anticancer Res"},{"key":"9255_CR25","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1093\/carcin\/16.7.1461","volume":"16","author":"A Sj\u00e4lander","year":"1995","unstructured":"Sj\u00e4lander A, Birgander R, Athlin L et al (1995) P53 germ line haplotypes associated with increased risk for colorectal cancer. Carcinogenesis 16:1461\u20131464","journal-title":"Carcinogenesis"},{"key":"9255_CR26","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1002\/ijc.22057","volume":"119","author":"A Koushik","year":"2006","unstructured":"Koushik A, Tranah GJ, Ma J et al (2006) p53 Arg72Pro polymorphism and risk of colorectal adenoma and cancer. Int J Cancer 119:1863\u20131868","journal-title":"Int J Cancer"},{"key":"9255_CR27","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1007\/s00535-007-2026-z","volume":"42","author":"MT Vietri","year":"2007","unstructured":"Vietri MT, Riegler G, Ursillo A et al (2007) p53 codon 72 polymorphism in patients affected with ulcerative colitis. J Gastroenterol 42:456\u2013460","journal-title":"J Gastroenterol"},{"key":"9255_CR28","first-page":"323","volume":"131","author":"MA Kaiser","year":"2001","unstructured":"Kaiser MA, Beart RW (2001) Surgical management of ulcerative colitis. Swiss Med Wkly 131:323\u2013337","journal-title":"Swiss Med Wkly"},{"key":"9255_CR29","volume-title":"Gastrointestinal disease volume 2 pathophysiology diagnosis management","author":"MH Sleisenger","year":"1989","unstructured":"Sleisenger MH, Fordtran JS (1989) Gastrointestinal disease volume 2 pathophysiology diagnosis management, 4th edn. Saunders, Philadelphia","edition":"4"},{"key":"9255_CR30","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/s00384-008-0509-x","volume":"23","author":"M Lampinen","year":"2008","unstructured":"Lampinen M, Sangfelt P, Taha Y, Carlson M (2008) Accumulation, activation, and survival of neutrophils in ulcerative colitis: regulation by locally produced factors in the colon and impact of steroid treatment. Int J Colorectal Dis 23:939\u2013946","journal-title":"Int J Colorectal Dis"},{"key":"9255_CR31","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1046\/j.1440-1746.2002.02791.x","volume":"17","author":"C Hagiwara","year":"2002","unstructured":"Hagiwara C, Tanaka M, Kudo H (2002) Increase in colorectal epithelial apoptotic cells in patients with ulcerative colitis ultimately requiring surgery. J Gastroenterol Hepatol 17:758\u2013764","journal-title":"J Gastroenterol Hepatol"},{"key":"9255_CR32","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s00535-008-2227-0","volume":"43","author":"S Yoshiyama","year":"2008","unstructured":"Yoshiyama S, Miki C, Okita Y, Araki T, Uchida K, Kusunoki M (2008) Neutrophil-related immunoinflammatory disturbance in steroid-overdosed ulcerative colitis patients. J Gastroenterol 43:789\u2013797","journal-title":"J Gastroenterol"},{"key":"9255_CR33","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1136\/gut.43.1.48","volume":"43","author":"H Ueyama","year":"1998","unstructured":"Ueyama H, Kiyohara T, Sawada N et al (1998) High Fas ligand expression on lymphocytes in lesions of ulcerative colitis. Gut 43:48\u201355","journal-title":"Gut"},{"key":"9255_CR34","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1128\/MCB.19.2.1092","volume":"19","author":"M Thomas","year":"1999","unstructured":"Thomas M, Kalita A, Labrecque S, Pim D, Banks L, Matlashwski G (1999) Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol Cell Biol 19:1092\u20131100","journal-title":"Mol Cell Biol"},{"key":"9255_CR35","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/ijc.11548","volume":"108","author":"D Pim","year":"2004","unstructured":"Pim D, Banks L (2004) p53 polymorphic variants at codon 72 exert different effects on cell cycle progression. Int J Cancer 108:196\u2013199","journal-title":"Int J Cancer"},{"key":"9255_CR36","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1096\/fj.04-3213fje","volume":"19","author":"EA Komarova","year":"2005","unstructured":"Komarova EA, Krivokrysenko V, Wang K et al (2005) p53 is a suppressor of inflammatory response in mice. FASEB J 19:1030\u20131032","journal-title":"FASEB J"}],"container-title":["Pathology &amp; Oncology Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-010-9255-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12253-010-9255-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-010-9255-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T02:39:13Z","timestamp":1559443153000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12253-010-9255-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,23]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["9255"],"URL":"https:\/\/doi.org\/10.1007\/s12253-010-9255-9","relation":{},"ISSN":["1219-4956","1532-2807"],"issn-type":[{"value":"1219-4956","type":"print"},{"value":"1532-2807","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3,23]]}}}